Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 75,500
-2,000 (-2.58%)
Last updated: Apr 9, 2026, 2:27 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 576.28 billion as of April 8, 2026.
Market Cap
576.28B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
75,500.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 576.28B, an increase of 156.62%. That is a compound annual growth rate of 1,178.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 576.28B | 47.62% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.08T |
| Myung In Pharmaceutical LTD. | 821.98B |
| ImmuneOncia Therapeutics | 559.95B |
| HEM Pharma | 455.40B |
| CellBion | 381.74B |
| GREEN CROSS WellBeing | 247.01B |
| DAE HWA Pharmaceutical | 244.01B |
| NOVAREX | 233.67B |